Table 1.
Comparison of factors among the patients with different distribution of atherosclerotic stenosis.
| All (n = 1,129) | Non-stenosis (n = 143) | Intracranial stenosis alone (n = 396) | Extracranial stenosis alone (n = 222) | Combined intra/extracranial stenosis (n = 368) | p | |
|---|---|---|---|---|---|---|
| Male, n (%) | 805 (71.3) | 92 (64.3) | 255 (64.4) | 180 (81.1) | 278 (75.5) | <0.001 |
| Age, median (IQR) | 62 (55, 68) | 59 (54, 65) | 59 (54, 66) | 64 (58, 70) | 63 (57, 70) | <0.001 |
| Medical history | ||||||
| Hypertension, n (%) | 778 (68.9) | 77 (53.8) | 270 (68.2) | 66 (29.7) | 275 (74.7) | <0.001 |
| Diabetes, n (%) | 335 (29.7) | 19 (13.3) | 108 (27.3) | 156 (70.3) | 142 (38.6) | <0.001 |
| Stroke, n (%) | 271 (24.0) | 26 (18.2) | 96 (24.2) | 66 (29.7) | 92 (25.0) | 0.36 |
| Smoking, n (%) | 363 (32.2) | 45 (31.5) | 115 (29.0) | 156 (70.3) | 130 (35.3) | 0.32 |
| WBC, median (IQR), 109/L | 6.36 (5.17, 7.68) | 6.09 (4.98, 7.64) | 6.28 (5.11, 7.59) | 6.16 (4.98, 7.40) | 6.62 (5.39, 7.83) | 0.03 |
| Platelet, median (IQR), 109/L | 199.00 (165.00, 237.00) | 201.00 (164.50, 235.00) | 197.50 (164.75, 234.25) | 188.00 (158.25, 224.00) | 208.00 (173.00, 248.00) | 0.002 |
| Neutrophil, median (IQR), 109/L | 4.00 (3.00, 5.02) | 3.57 (2.80, 4.70) | 3.95 (3.00, 5.10) | 3.91 (3.00, 4.92) | 4.26 (3.11, 5.13) | 0.002 |
| Lymphocyte, median (IQR), 109/L | 1.60 (1.30, 2.00) | 1.73 (1.40, 2.32) | 1.57 (1.20, 2.00) | 1.50 (1.21, 1.81) | 1.60 (1.30, 1.96) | <0.001 |
| Monocyte, median (IQR), 109/L | 0.50 (0.40, 0.60) | 0.50 (0.40, 0.60) | 0.49 (0.39, 0.60) | 0.50 (0.40, 0.61) | 0.50 (0.40, 0.60) | 0.04 |
| TC, median (IQR), mmol/L | 4.01 (3.33, 4.79) | 4.09 (3.47, 4.88) | 3.96 (3.26, 4.80) | 3.90 (3.31, 4.59) | 4.08 (3.38, 4.78) | 0.32 |
| TG, median (IQR), mmol/L | 1.40 (0.99, 1.89) | 1.37 (0.95, 1.94) | 1.42 (0.98, 1.89) | 1.33 (0.98, 1.73) | 1.46 (1.08, 1.96) | 0.02 |
| HDL, median (IQR), mmol/L | 0.99 (0.85, 1.16) | 1.04 (0.92, 1.22) | 0.97 (0.83, 1.15) | 1.04 (0.86, 1.17) | 0.96 (0.84, 1.13) | 0.001 |
| LDL, median (IQR), mmol/L | 2.43 (1.89, 3.08) | 2.47 (1.94, 3.00) | 2.34 (1.85, 3.10) | 2.38 (1.88, 3.05) | 2.48 (1.91, 3.08) | 0.52 |
| Lpa, median (IQR), mg/L | 130.80 (61.20, 286.80) | 109.30 (57.65, 229.15) | 129.55 (57.70, 261.47) | 121.45 (62.50, 319.60) | 145.55 (63.17, 331.22) | 0.052 |
| MHR, median (IQR) | 0.50 (0.37, 0.65) | 0.48 (0.34, 0.62) | 0.49 (0.36, 0.63) | 0.48 (0.37, 0.64) | 0.52 (0.40, 0.68) | 0.010 |
| NLR, median (IQR) | 2.39 (1.84, 3.42) | 2.08 (1.57, 2.49) | 2.39 (1.90, 3.33) | 2.60 (1.90, 3.65) | 2.50 (1.90, 3.68) | <0.001 |
WBC, white blood cell; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Lpa, Lipoprotein(a); MHR, monocyte to HDL ratio; NLR, neutrophil-to-lymphocyte ratio; IQR, interquartile range; p for comparisons between intracranial stenosis/extracranial stenosis/combined intracranial and extracranial stenosis. The bold values indicate the significant values (p < 0.05).